Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-12 of 12
Keywords: CA 125
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Gynecol Obstet Invest (1986) 21 (1): 47–51.
Published Online: 15 March 2010
...F. Pansini; A. Bellinazzi; V. Rainaldi; M. Santoiemma; B. Lenzi; M. Jacobs; G. Mollica; B. Bagni Serum CA 125 was detected by RIA in a total of 66 patients with various ovarian pathologies (16 malignant and 50 benign). Six patients with ovarian carcinoma were monitored during the 1st week after...
Journal Articles
Yoshiyuki Negishi, Toshihito Furukawa, Takashi Oka, Masaru Sakamoto, Takao Hirata, Kazuhiro Okabe, Kunio Matayoshi, Kiyoshi Akiya, Hiroaki Soma
Gynecol Obstet Invest (1987) 23 (3): 200–207.
Published Online: 15 March 2010
...Yoshiyuki Negishi; Toshihito Furukawa; Takashi Oka; Masaru Sakamoto; Takao Hirata; Kazuhiro Okabe; Kunio Matayoshi; Kiyoshi Akiya; Hiroaki Soma The serum levels of CA 125 and CA 19-9 were determined by an immunoradiometric assay employing the monoclonal antibody OC 125 and anti-CA 19-9 antibody...
Journal Articles
Gynecol Obstet Invest (1987) 23 (4): 257–260.
Published Online: 15 March 2010
...Kentaro Takahashi; Yoshio Yamane; Satoshi Kijima; Kazuo Yoshino; Toshihiko Shibukawa; Manabu Kitao We measured serum levels of CA 125 in 26 patients with external endometriosis, using CA 125 RIA Kits. The normal range was instituted below 39 U/ml. The mean CA 125 level ( ± SD) was 55.1 ± 24.9 U/ml...
Journal Articles
Gynecol Obstet Invest (1987) 23 (2): 122–123.
Published Online: 15 March 2010
...Satoshi Kijima; Kentaro Takahashi; Manabu Kitao To investigate the histogenic and cytogenic localization of CA 125 in patients with adenomyosis, sections from 8 adenomyosis cases were expressed with monoclonal anti-CA 125 antibodies. Consequently, CA 125 proved to be present on the glandular...
Journal Articles
Gynecol Obstet Invest (1989) 28 (3): 165–168.
Published Online: 02 March 2010
... cases with benign disease who showed high values of tumor markers (CA 125 and CA 19–9). In this report, we illustrated 3 patients with endometriosis who showed high values of CA 125 and 2 patients with dermoid cyst who showed high values of CA 19–9. It was impossible to rule out malignant disease in all...
Journal Articles
Gynecol Obstet Invest (1990) 30 (1): 52–58.
Published Online: 02 March 2010
.... Of the histological type, it is interesting to note the relatively high sensitivity in patients with mucinous adenocarcinoma and clear cell carcinoma in contrast with the CA 125 antigen levels. Although the percentage of patients with ovarian cancer who had elevated sialyl SSEA-1 antigen levels is lower than...
Journal Articles
Gynecol Obstet Invest (1989) 28 (1): 11–13.
Published Online: 02 March 2010
...Lothar Clemens Fuith; Günther Daxenbichler; Christian Marth CA 125 serum concentrations drawn immediately following delivery exceeded 35 U/ml in all cases (median 276 U/ml). One week post partum elevations of CA 125 were still found, but the median level decreased to 45 U/ml. Six weeks after...
Journal Articles
Kentaro Takahashi, Hiroko Nagata, Satoshi Kijima, Masuo Kusakari, Takaaki Shirai, Kazuo Yoshino, Manabu Kitao
Gynecol Obstet Invest (1988) 26 (1): 63–65.
Published Online: 02 March 2010
...Kentaro Takahashi; Hiroko Nagata; Satoshi Kijima; Masuo Kusakari; Takaaki Shirai; Kazuo Yoshino; Manabu Kitao We measured CA 125 levels in sera and menstrual blood of subjects with a normal ovulatory cycle and in those with endometriosis. Serum CA 125 levels were higher in the latter, in each phase...
Journal Articles
Gynecol Obstet Invest (1995) 40 (1): 61–63.
Published Online: 01 March 2010
...Stefano Guerriero; Silvia Ajossa; Antonio Cafflero; Valerio Mais Two premenopausal women presented with endometrioma and slightly elevated CA 125 plasma levels (42.5 and 39.0 U/ml). After initial evaluation, both patients had an episode of sudden onset of pelvic pain with rapid resolution after...
Journal Articles
Gynecol Obstet Invest (1994) 37 (3): 199–203.
Published Online: 01 March 2010
..., or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. CA 125...
Journal Articles
Gynecol Obstet Invest (2003) 54 (3): 132–136.
Published Online: 14 February 2003
...Francisco José Candido dos Reis; Jurandyr Moreira de Andrade; Sérgio Bighetti Tumor markers have been investigated in differentiation of benign and malignant tumors. We analyzed CA 125 and vascular endothelial growth factor (VEGF) levels in serum and cyst fluid in patients with epithelial ovarian...
Journal Articles
Gynecol Obstet Invest (1999) 48 (2): 133–137.
Published Online: 13 August 1999
..., measurement of c- erb B-2 ECD when used alone or in combination with CA 125 is not useful in differentiating benign from malignant ovarian tumors. 13 8 1999 1999 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other...